These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11686868)

  • 41. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation.
    Yang L; Cohn L; Zhang DH; Homer R; Ray A; Ray P
    J Exp Med; 1998 Nov; 188(9):1739-50. PubMed ID: 9802985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
    Hilvering B; Xue L; Pavord ID
    Ther Adv Respir Dis; 2015 Aug; 9(4):135-45. PubMed ID: 25900924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active immunotherapy of allergic asthma with a recombinant human interleukin-5 protein as vaccine in a murine model.
    Tan GH; Wang CC; Huang FY; Wang H; Huang YH; Lin YY
    Chin Med J (Engl); 2007 Sep; 120(17):1517-22. PubMed ID: 17908461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-interleukin-5 therapy for eosinophilic diseases].
    Simon D; Braathen LR; Simon HU
    Hautarzt; 2007 Feb; 58(2):122, 124-7. PubMed ID: 17221241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-18 and allergic asthma.
    Wild JS; Sur S
    Isr Med Assoc J; 2000 Dec; 2 Suppl():16-8. PubMed ID: 11344858
    [No Abstract]   [Full Text] [Related]  

  • 47. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma.
    Hertz M; Mahalingam S; Dalum I; Klysner S; Mattes J; Neisig A; Mouritsen S; Foster PS; Gautam A
    J Immunol; 2001 Oct; 167(7):3792-9. PubMed ID: 11564796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment of T-helper type 2 clone-induced eosinophilia in mouse conjunctiva.
    Hamada M; Sawa K; Nakata K
    Exp Eye Res; 1999 Jul; 69(1):69-74. PubMed ID: 10375450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TNF-α enhance Th2 and Th17 immune responses regulating by IL23 during sensitization in asthma model.
    Lee HS; Park HW; Song WJ; Jeon EY; Bang B; Shim EJ; Moon HG; Kim YK; Kang HR; Min KU; Cho SH
    Cytokine; 2016 Mar; 79():23-30. PubMed ID: 26717421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-5: a novel target for asthma therapy.
    Blümchen K; Kallinich T; Hamelmann E
    Expert Opin Biol Ther; 2001 May; 1(3):433-53. PubMed ID: 11727517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma.
    Wild JS; Sigounas A; Sur N; Siddiqui MS; Alam R; Kurimoto M; Sur S
    J Immunol; 2000 Mar; 164(5):2701-10. PubMed ID: 10679111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
    Esnault S; Kelly EA
    Crit Rev Immunol; 2016; 36(5):429-444. PubMed ID: 28605348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation.
    Gil MA; Caniga M; Woodhouse JD; Eckman J; Lee HH; Salmon M; Naber J; Hamilton VT; Sevilla RS; Bettano K; Klappenbach J; Moy L; Correll CC; Gervais FG; Siliphaivanh P; Zhang W; Zhang-Hoover J; McLeod RL; Cicmil M
    Eur J Pharmacol; 2014 Nov; 743():106-16. PubMed ID: 25261040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses.
    Phipps S; Lam CE; Kaiko GE; Foo SY; Collison A; Mattes J; Barry J; Davidson S; Oreo K; Smith L; Mansell A; Matthaei KI; Foster PS
    Am J Respir Crit Care Med; 2009 May; 179(10):883-93. PubMed ID: 19246719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials.
    Wang FP; Xiong XF; Liu T; Li SY; Cheng DY; Mao H
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):318-330. PubMed ID: 27677499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma.
    Calixto MC; Lintomen L; Schenka A; Saad MJ; Zanesco A; Antunes E
    Br J Pharmacol; 2010 Feb; 159(3):617-25. PubMed ID: 20100278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels.
    Hofstra CL; Van Ark I; Hofman G; Kool M; Nijkamp FP; Van Oosterhout AJ
    J Immunol; 1998 Nov; 161(9):5054-60. PubMed ID: 9794443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B.
    Hellings PW; Hens G; Meyts I; Bullens D; Vanoirbeek J; Gevaert P; Jorissen M; Ceuppens JL; Bachert C
    Clin Exp Allergy; 2006 Aug; 36(8):1063-71. PubMed ID: 16911362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete dependence on CD4+ cells in late asthmatic response, but limited contribution of the cells to airway remodeling in sensitized mice.
    Nabe T; Morishita T; Matsuya K; Ikedo A; Fujii M; Mizutani N; Yoshino S
    J Pharmacol Sci; 2011; 116(4):373-83. PubMed ID: 21778663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.